Slide 1Prof. Rosanna Abbate Univ.di Firenze Slide 2 Commonly-used anticoagulant treatments affect several steps of coagulation pathway Clot Intrinsic pathwayExtrinsic pathway…

Slide 1Gli anticoagulanti di ultima generazione Ida Martinelli Centro Emofilia e Trombosi A. Bianchi Bonomi Fondazione IRCCS Ca Granda - Ospedale Maggiore Policlinico Milano…

Slide 1Rivaroxaban compared with enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients Alexander T Cohen On behalf of the MAGELLAN Steering…

Slide 1 Paziente medico e chirurgico: schemi di trattamento Walter Ageno Dipartimento di Medicina Clinica Università dellInsubria - Varese Slide 2 Slide 3 MEDENOX (enoxaparin)…

1. Neurology Morning Report Cathy Larrain, MD, PGY3 Internal Medicine August 3, 2010 2.  41 year-old male with no known past medical history presents with acute onset…

1. i Preventing Venous Thromboembolism: Prophylactic Options for Patients at Different Risk Levels James P. Kahan Marleen Cornelis Han de Vries Ineke van Beusekom Vincent…

1. i Preventing Venous Thromboembolism: Prophylactic Options for Patients at Different Risk Levels James P. Kahan Marleen Cornelis Han de Vries Ineke van Beusekom Vincent…

1. Running head: PREVENTION OF VENOUS THROMBOEMBOLISM 1 Prevention of Venous Thromboembolism After Hip or Knee Replacement Molly P. Bruce Georgetown University School of…

Slide 1 Surgical Foundations January 27, 2015 Bill Geerts, MD, FRCPC Thromboembolism Consultant, Sunnybrook HSC Professor of Medicine, University of Toronto National Lead,…

Slide 1 DVT Prophylaxis in Orthopedic Patients Rogers Kyle, MD Medical University of South Carolina 11/27/12 Slide 2 Objectives Review the newest ACCP recommendations on…